Navigation Links
Investor Group Commends Clint Severson for Joining Trinity Biotech's Board of Directors
Date:11/20/2008

KANSAS CITY, Mo., Nov. 20 /PRNewswire/ -- An investor group in Trinity Biotech plc (Nasdaq: TRIB), an Irish based developer and manufacturer of diagnostic products whose shares are traded in the form of American Depository Receipts on NASDAQ, is encouraged that Clint Severson has joined the company's board of directors.

Commenting on the news, Tom Reidy stated, "We are delighted that Clint has agreed to serve as an independent director, bringing the total of independent directors to two. While Clint's appointment is a step in the right direction, we continue to believe that the election of an independent director controlled board is essential to an increase in company share value. We look forward to Clint remaining as part of our new board immediately following our pending action to remove and replace the current board."

In October, the investor group directed that Trinity Biotech shareholders be given the opportunity to vote on a slate of replacement directors, including Mr. Severson. The remaining proposed slate consists of the following individuals:

     1. Dr. Jack C. Chow, M.D., M.B.A. -- Partner, CRV Capital, LLC and
        adjunct professor at Carnegie Mellon University's Heinz School of
        Public Policy and Management;
     2. Mr. Mike Gausling -- Managing Partner, Originate Ventures;
     3. Dr. John H. Halsey, Ph.D. -- Chief Executive Officer, Director,
        Founder, ProGene Biomedical, Inc. (dba IBT Laboratories);
     4. Mr. Steven A. Mock, CPA -- Partner, BKD, LLP; and
     5. Mr. Thomas Reidy.

Further commenting on the appointment of Mr. Severson, Tom Reidy stated that 'based on several conversations with Mr. Severson, I believe we are totally aligned on the aspects of effective corporate governance, transparency of board and company actions, and performance-based remuneration programs. Clint's emphasis on management accountability and the need for sharp focus and effective strategic planning are essential in today's marketplace. We just need more people like Clint on the board '.


'/>"/>
SOURCE KC Investor Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. SXC Health Solutions to host analyst and institutional investor event
2. Unilever Investor Relations Seminar
3. ProAssurance to Present at Oppenheimer Investor Conference
4. Surgical Care Affiliates Announces Investor Conference Call to Discuss Third Quarter 2008 Results
5. Alexion to Present at Investor Conferences
6. Jazz Pharmaceuticals to Present at Investor Conferences
7. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
8. BD to Present at Investor Healthcare Conferences
9. VirtualScopics to Present at Two Upcoming Investor Conferences
10. Pregis Announces Investor Conference Call to Review 2008 Third Quarter Financial Results
11. Robbins & Myers to Present at Sidoti & Company Investor Conference on November 10, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... IL (PRWEB) , ... December 07, 2016 , ... AlignLife ... season. Many children are not fortunate enough to receive bountiful gifts wrapped tightly ... unwrapping presents can bring to the children of the world. , In exchange for ...
(Date:12/7/2016)... ... OCTOBER XX, 2016 (PRWEB) (PRWEB) December 07, 2016 ... ... A new study entitled “Canine Filamentous Dermatitis Associated with Borrelia Infection” ... dogs. The study was published in the prestigious Journal of Veterinary Science & ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... that its fully redesigned website, which launched October 17, 2016, features comprehensive information ... design and easy-to-navigate layout. Visitors and patients can discover the latest clinical dermatology ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and Laser ... Holiday Party Season. Save Up To 33% Off Botox® and Juvederm® Products Now Through ... Phoenix Valley with Delightful Deals on Botox® and Juvederm® just in time ...
(Date:12/7/2016)... ... December 07, 2016 , ... 1105 Media’s ... in the Folio: Marketing Awards competition. Live From won in the Use of ... inventive, and ultimately successful projects undertaken by the media industry’s most innovative marketing ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- According to responses from U.S. oncologists that participated in ... with non-small cell lung cancer (NSCLC), treatment decisions are made ... status. The findings of the survey were presented today as ... ) at the 2016 World Conference on Lung Cancer (WCLC) ... survey results revealed an overall high rate of EGFR mutation ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 ... II trial in patients with unresectable malignant pleural ... survival (PFS). The data, presented at the 17 ... in Vienna , showed nintedanib ... to placebo plus pemetrexed/cisplatin, with a significantly improved ...
(Date:12/7/2016)... YORK , December 7, 2016 ... Pharmaceuticals PLC (NASDAQ: JAZZ ), Anthera Pharmaceuticals Inc. ... DNAI ), and AveXis Inc. (NASDAQ: AVXS ... Sector Index fell roughly 37% to reach a level equal ... it is down by approximately 14% for the year, it ...
Breaking Medicine Technology: